# FDA Inspection 961640 - Seattle Reproductive Medicine, Inc., P.S. - February 10, 2016

Source: https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/4ced1bed-ae6c-4311-8561-538cdcbaaa72
Source feed: FDA_Inspections

> FDA Inspection 961640 for Seattle Reproductive Medicine, Inc., P.S. on February 10, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 961640
- Company Name: Seattle Reproductive Medicine, Inc., P.S.
- Inspection Date: 2016-02-10
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1293422 - 2025-09-16](https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/ab83dfac-9339-40f0-98b5-41a9492e3b47)
- [FDA Inspection 1293422 - 2025-09-16](https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/5938bff5-6d1a-4b6f-a069-399106a1da5f)
- [FDA Inspection 1171334 - 2022-04-07](https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/af54c5cd-7d22-4560-b8ef-7cfc2a462faa)
- [FDA Inspection 1171334 - 2022-04-07](https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/28067377-fc05-4d9a-9512-dfdd85dca441)
- [FDA Inspection 1171334 - 2022-04-07](https://www.keypedia.com/records/fda_inspections/seattle-reproductive-medicine-inc-ps/5c86d0bf-066e-4a9a-a4d8-83cb7d48358e)

Company: https://www.keypedia.com/companies/seattle-reproductive-medicine-inc-ps/a65e1f0e-6645-4092-a3d7-cce342cdd872

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d